<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="osanctum-searched/PMC5965372/results/search/drugs/results.xml">
  <result pre="supplemented with 1% nonessential amino acid, 10% v/v FBS, 1%" exact="l-glutamine" post="(Thermo Fisher Scientific), and 100 µg/mL penicillin/streptomycin (Sigma-Aldrich Co.)"/>
  <result pre="flasks comprising DMEM added with 1% antibiotics (100 µg/mL of" exact="streptomycin" post="and 100 U/mL of penicillin) and 10% FBS. The"/>
  <result pre="promoter. 16 The cells were treated with vehicle, Vicenin-2, or" exact="lithium" post="chloride (LiCl) 48 hours after transfection, and activity of"/>
  <result pre="medium to starve the cells. The cells were treated with" exact="dimethyl sulfoxide" post="(vehicle) and 50 µM of Vicenin-2 after starvation. After"/>
  <result pre="the resistance of HCT116 colon cancer cells to 5-FU and" exact="oxaliplatin" post="Cell Commun Signal 2017 15 1 9 28143584 23"/>
  <result pre="pharmacological interactions of the protein kinase C-beta inhibitor enzastaurin and" exact="erlotinib" post="in non-small cell lung cancer cells Am J Cancer"/>
  <result pre="vicenin-2 as a single agent and in synergistic combination with" exact="docetaxel" post="in prostate cancer Biochem Pharmacol 2011 82 9 1100"/>
 </snippets>
</snippetsTree>
